closure glaucoma, followed by pseudoexfoliative glaucoma and then primary open-angle glaucoma. However, the authors noted the lack of high-quality evidence and suggested that additional data were needed to confirm these findings. 1 Data derived secondarily from randomized clinical trials support this relationship between cataract surgery and improved IOP. For example, Mansberger and colleagues 2 leveraged data from the Ocular Hypertension Treatment Study, a multicenter, prospective, randomized clinical trial that rigorously monitored IOP for patients with ocular hypertension assigned to either topical IOP medication or observation. 2 They found that nearly 40% of unmedicated eyes had a 20% or greater IOP reduction followed by cataract surgery. This difference was sustained for at least a year and diminished but persisted for additional 2 years. In addition, data derived from pivotal trials involving minimally invasive glaucoma surgery devices consistently demonstrate that those patients included in the control arm to receive stand-alone cataract surgery demonstrate improved average IOPs. The first-generation trabecular micro-bypass iStent (Glaukos Corporation, San Clemente, CA) found that, while eyes implanted with the iStent were more likely to meet various IOP thresholds at 12 months, 50% of eyes with stand-alone cataract surgery had a 20% or greater IOP reduction. 3 Similarly, the two-year results of the second-generation iStent reported a mean IOP reduction of 5.4 mm Hg from baseline and nearly 62% with 20% or greater IOP reduction for eyes receiving stand-along cataract surgery. 4 The long-term results for the Hydrus trabecular micro-stent (Alcon, Fort Worth, TX) also suggested sustained IOP reduction in eyes with stand-alone cataract surgery through 5 years. 5 Results from studies leveraging clinical registries echo the findings described previously. For example, the Swedish National Cataract Register prospectively collected data on 20,437 eyes that underwent stand-alone cataract surgery and calculated a mean IOP reduction of 1.46 mm Hg. Greater IOP reduction was associated with greater baseline IOP, older age, shorter eyes, and diagnoses of glaucoma and pseudoexfoliation. 6 Similarly, Wang et al. 7 created a text-processing algorithm that extracted data from electronic medical record free text on 4882 patients with 7574 cataract surgeries and found a sustained IOP reduction after cataract surgery through 14 months. Their multivariate analysis of predictors of IOP reduction found that, compared with eyes without glaucoma, diagnoses of primary open-angle glaucoma and narrow or closed angles had greater odds of IOP reduction. In addition, every 1 mm Hg increase in baseline IOP increased the odds of an IOP reduction after cataract surgery by 6%.The American Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight) is a large, de-identified clinical data registry that consists of clinical and billing data on over 70 million unique patients with nearly 500 million unique patient encounters. 8 A rece...